Certified by Founder Lodge
Atlas Venture
United States - Cambridge, MA
INVESTOR
1 Disclosed Funding Rounds $100,000,000
83 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Atlas Venture is a leading biotech venture capital firm. With the goal of doing well by doing good, we have been building breakthrough biotech startups since 1993. We work side by side with e
| Company | Date | Round | Raised |
|---|---|---|---|
 Nimbus Therapeutics |
September, 13 ,2022 | Unknown | $125,000,000 |
 Aiolos Bio |
October, 26 ,2023 | Series A | $245,000,000 |
| Aiolos Bio |
October, 26 ,2023 | Series A | $245,000,000 |
 AAVantgarde Bio |
June, 07 ,2023 | Series A | $65,333,745 |
| Aiolos Bio |
October, 26 ,2023 | Series A | $245,000,000 |
| AAVantgarde Bio |
June, 07 ,2023 | Series A | $65,333,745 |
 Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
 Matchpoint Therapeutics |
October, 17 ,2022 | Series A | $100,000,000 |
| AAVantgarde Bio |
June, 07 ,2023 | Series A | $65,333,745 |
 Mariana Oncology |
September, 08 ,2023 | Series B | $175,000,000 |
 Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
| Mariana Oncology |
September, 08 ,2023 | Series B | $175,000,000 |
| Mariana Oncology |
September, 08 ,2023 | Series B | $175,000,000 |
| Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
 Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Nimbus Therapeutics |
September, 13 ,2022 | Unknown | $125,000,000 |
| Aiolos Bio |
October, 26 ,2023 | Series A | $245,000,000 |
| Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
| Aiolos Bio |
October, 26 ,2023 | Series A | $245,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Aiolos Bio |
October, 26 ,2023 | Series A | $245,000,000 |
| AAVantgarde Bio |
June, 07 ,2023 | Series A | $65,333,745 |
 Pheon Therapeutics |
May, 21 ,2024 | Series B | $120,000,000 |
| Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Mariana Oncology |
September, 08 ,2023 | Series B | $175,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
| Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
 Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Aiolos Bio |
October, 26 ,2023 | Series A | $245,000,000 |
| Pheon Therapeutics |
May, 21 ,2024 | Series B | $120,000,000 |
| Pheon Therapeutics |
May, 21 ,2024 | Series B | $120,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
 GRO Biosciences |
July, 23 ,2024 | Series B | $60,300,000 |
| Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
| Pheon Therapeutics |
May, 21 ,2024 | Series B | $120,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Pheon Therapeutics |
May, 21 ,2024 | Series B | $120,000,000 |
| GRO Biosciences |
July, 23 ,2024 | Series B | $60,300,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| GRO Biosciences |
July, 23 ,2024 | Series B | $60,300,000 |
 PHINXT Robotics |
August, 06 ,2024 | Unknown | $2,549,120 |
| Pheon Therapeutics |
May, 21 ,2024 | Series B | $120,000,000 |
| Pheon Therapeutics |
May, 21 ,2024 | Series B | $120,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
 Judo Bio |
October, 08 ,2024 | Seed | $100,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| GRO Biosciences |
July, 23 ,2024 | Series B | $60,300,000 |
| GRO Biosciences |
July, 23 ,2024 | Series B | $60,300,000 |
 Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| PHINXT Robotics |
August, 06 ,2024 | Unknown | $2,549,120 |
 Vima Therapeutics |
May, 30 ,2025 | Series A | $60,000,000 |
| Pheon Therapeutics |
May, 21 ,2024 | Series B | $120,000,000 |
| GRO Biosciences |
July, 23 ,2024 | Series B | $60,300,000 |
| Judo Bio |
October, 08 ,2024 | Seed | $100,000,000 |
| PHINXT Robotics |
August, 06 ,2024 | Unknown | $2,549,120 |
| GRO Biosciences |
July, 23 ,2024 | Series B | $60,300,000 |
| Judo Bio |
October, 08 ,2024 | Seed | $100,000,000 |
| Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
| Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Vima Therapeutics |
May, 30 ,2025 | Series A | $60,000,000 |
| Vima Therapeutics |
May, 30 ,2025 | Series A | $60,000,000 |
 Antares Therapeutics |
June, 11 ,2025 | Series A | $117,000,000 |
| GRO Biosciences |
July, 23 ,2024 | Series B | $60,300,000 |
| PHINXT Robotics |
August, 06 ,2024 | Unknown | $2,549,120 |
| Judo Bio |
October, 08 ,2024 | Seed | $100,000,000 |
| Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
| Vima Therapeutics |
May, 30 ,2025 | Series A | $60,000,000 |
| Antares Therapeutics |
June, 11 ,2025 | Series A | $117,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
